메뉴 건너뛰기




Volumn 1220, Issue C, 2001, Pages 35-50

The use of cognitive tests to facilitate drug and dose selection in Phase I and to optimise dosing in Phase IV

Author keywords

Automated testing; Cognition enhancers; Drug development; Human cognitive function; Scopolamine models

Indexed keywords


EID: 0038176085     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00285-0     Document Type: Article
Times cited : (8)

References (49)
  • 1
    • 0017361403 scopus 로고
    • The effects of psychotropic drugs on human behaviour
    • Wesnes, K.A., The effects of psychotropic drugs on human behaviour. Mod. Probl. Pharmacopsychiatry 12 (1977), 37–58.
    • (1977) Mod. Probl. Pharmacopsychiatry , vol.12 , pp. 37-58
    • Wesnes, K.A.1
  • 2
    • 0025981522 scopus 로고
    • The cognitive drug research computerised assessment system for demented patients: a validation study
    • Simpson, P.M., Surmon, D.J., Wesnes, K.A., Wilcock, G.R., The cognitive drug research computerised assessment system for demented patients: a validation study. Int. J. Geriatr. Psychopharmacol. 6 (1991), 95–102.
    • (1991) Int. J. Geriatr. Psychopharmacol. , vol.6 , pp. 95-102
    • Simpson, P.M.1    Surmon, D.J.2    Wesnes, K.A.3    Wilcock, G.R.4
  • 3
    • 0001003915 scopus 로고
    • A computerised system for the assessment of drug-induced performance changes in young elderly or demented populations
    • Simpson, P.M., Wesnes, K.A., Christmas, L, A computerised system for the assessment of drug-induced performance changes in young elderly or demented populations. Br. J. Clin. Pharmacol. 27 (1989), 711P–712P.
    • (1989) Br. J. Clin. Pharmacol. , vol.27 , pp. 711P-712P
    • Simpson, P.M.1    Wesnes, K.A.2    Christmas, L.3
  • 4
    • 27544484649 scopus 로고
    • The relationships between P300 and cognitive processing in simple and choice reaction tasks
    • McClelland, G.R., Wesnes, K.A., The relationships between P300 and cognitive processing in simple and choice reaction tasks. J. Psychopharmacol., 9, 1995, A39 Suppl.
    • (1995) J. Psychopharmacol. , vol.9 , pp. A39
    • McClelland, G.R.1    Wesnes, K.A.2
  • 5
    • 0030460306 scopus 로고    scopus 로고
    • The utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia
    • Mohr, E, Walker, D, Randolph, C, Sampson, M, Mendis, T, The utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia. Int. Psychogeriatr. 3 (1996), 397–411.
    • (1996) Int. Psychogeriatr. , vol.3 , pp. 397-411
    • Mohr, E.1    Walker, D.2    Randolph, C.3    Sampson, M.4    Mendis, T.5
  • 7
    • 4243286970 scopus 로고    scopus 로고
    • Validity and utility of the CDR computerised cognitive assessment system: a review following 15 years of use
    • Ward, T, Wesnes, K.A., Validity and utility of the CDR computerised cognitive assessment system: a review following 15 years of use. J. Psychopharmacol., 13(Suppl. A), 1999, A25.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A25
    • Ward, T.1    Wesnes, K.A.2
  • 8
    • 4243350118 scopus 로고    scopus 로고
    • Cognitive effects of single doses of ME3127, a novel anxiolytic in volunteers
    • Jones, S, Jensen, N.O., Oliver, S, Wesnes, K.A., Cognitive effects of single doses of ME3127, a novel anxiolytic in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A27
    • Jones, S.1    Jensen, N.O.2    Oliver, S.3    Wesnes, K.A.4
  • 9
    • 4243350118 scopus 로고    scopus 로고
    • Cognitive effects of multiple doses of ME3127, a novel anxiolytic, in volunteers
    • Pincock, C, Jensen, N.O., Oliver, S, Wesnes, K.A., Jones, S, Cognitive effects of multiple doses of ME3127, a novel anxiolytic, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A27
    • Pincock, C.1    Jensen, N.O.2    Oliver, S.3    Wesnes, K.A.4    Jones, S.5
  • 10
    • 27544490457 scopus 로고    scopus 로고
    • Cognitive effects of NS2389, a serotonin reuptake inhibitor, in healthy volunteers
    • Russell-Duff, K, Jensen, N.O., Mooney, P, Wesnes, K.A., Cognitive effects of NS2389, a serotonin reuptake inhibitor, in healthy volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A27
    • Russell-Duff, K.1    Jensen, N.O.2    Mooney, P.3    Wesnes, K.A.4
  • 11
    • 0002739064 scopus 로고
    • The cognitive effects of single and multiple doses of UK 76,654, a selective M3 muscarinic antagonist in healthy volunteers
    • McEwen, J, Wesnes, K.A., Rapeport, W.G., Williams, S, The cognitive effects of single and multiple doses of UK 76,654, a selective M3 muscarinic antagonist in healthy volunteers. Eur. J. Clin. Invest., 25(Suppl. 2), 1995, A64.
    • (1995) Eur. J. Clin. Invest. , vol.25 , pp. A64
    • McEwen, J.1    Wesnes, K.A.2    Rapeport, W.G.3    Williams, S.4
  • 13
    • 0342649641 scopus 로고
    • A comparison of the cognitive effects of DU29894, sulpiride, haloperidol and a selective 5HT1A agonist in normal volunteers
    • Wesnes, K.A., de Koning, P, Dietrich, B, A comparison of the cognitive effects of DU29894, sulpiride, haloperidol and a selective 5HT1A agonist in normal volunteers. Eur. J. Clin. Invest., 25(Suppl. 2), 1995, A64.
    • (1995) Eur. J. Clin. Invest. , vol.25 , pp. A64
    • Wesnes, K.A.1    de Koning, P.2    Dietrich, B.3
  • 14
    • 0032998303 scopus 로고    scopus 로고
    • A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers
    • Beuzen, J.-N., Taylor, N, Wesnes, K, Wood, A, A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J. Psychopharmacol. 13 (1999), 152–158.
    • (1999) J. Psychopharmacol. , vol.13 , pp. 152-158
    • Beuzen, J.-N.1    Taylor, N.2    Wesnes, K.3    Wood, A.4
  • 15
    • 26144462900 scopus 로고    scopus 로고
    • Cognitive function is unaffected by remacemide at therapeutically relevant single doses
    • Lockton, J.A., Cole, G, Hammersley, M, Wesnes, K.A., Cognitive function is unaffected by remacemide at therapeutically relevant single doses. J. Psychopharmacol., 12(Supplement A), 1998, A41.
    • (1998) J. Psychopharmacol. , vol.12 , pp. A41
    • Lockton, J.A.1    Cole, G.2    Hammersley, M.3    Wesnes, K.A.4
  • 16
    • 26144442419 scopus 로고    scopus 로고
    • Remacemide does not affect cognitive function following multiple dosing
    • Lockton, J.A., Wesnes, K.A., Yeates, N, Rolan, P, Diggory, G, Remacemide does not affect cognitive function following multiple dosing. J. Psychopharmacol., 12(Supplement A), 1998, A41.
    • (1998) J. Psychopharmacol. , vol.12 , pp. A41
    • Lockton, J.A.1    Wesnes, K.A.2    Yeates, N.3    Rolan, P.4    Diggory, G.5
  • 17
    • 4243882084 scopus 로고    scopus 로고
    • Cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers
    • Wills, K, Jensen, N.O., Oliver, S, Wesnes, K.A., Cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A27
    • Wills, K.1    Jensen, N.O.2    Oliver, S.3    Wesnes, K.A.4
  • 18
    • 4244020303 scopus 로고    scopus 로고
    • First in man cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers
    • Jones, S, Jensen, N.O., Oliver, S, Wesnes, K.A., First in man cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A26.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A26
    • Jones, S.1    Jensen, N.O.2    Oliver, S.3    Wesnes, K.A.4
  • 19
    • 4243212877 scopus 로고    scopus 로고
    • First cognitive effects of NS2359, a noradrenaline, dopamine and serotonin reuptake inhibitor, in volunteers
    • Bosworth, J, Jensen, N.O., Oliver, S, Wesnes, K.A., First cognitive effects of NS2359, a noradrenaline, dopamine and serotonin reuptake inhibitor, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A26.
    • (1999) J. Psychopharmacol. , vol.13 , pp. A26
    • Bosworth, J.1    Jensen, N.O.2    Oliver, S.3    Wesnes, K.A.4
  • 20
    • 0001045856 scopus 로고    scopus 로고
    • Phase I studies of GTS-21 to assess the safety, tolerability, PK and effects on measures of cognitive function in normal volunteers
    • Kitagawa, H, Moriyama, A, Takenouchi, T, Wesnes, K.A., Kramer, W, Clody, D.E., Phase I studies of GTS-21 to assess the safety, tolerability, PK and effects on measures of cognitive function in normal volunteers. Neurobiol. Aging, 19(Supplement 2), 1998, S182.
    • (1998) Neurobiol. Aging , vol.19 , pp. S182
    • Kitagawa, H.1    Moriyama, A.2    Takenouchi, T.3    Wesnes, K.A.4    Kramer, W.5    Clody, D.E.6
  • 21
    • 0001766901 scopus 로고
    • Smoking, nicotine and human performance
    • A Smith D Jones Academic Press London
    • Wesnes, K.A., Parrott, A, Smoking, nicotine and human performance. Smith, A, Jones, D, (eds.) Handbook of Human Performance, vol. 2, 1992, Academic Press, London, 127–167.
    • (1992) Handbook of Human Performance , vol.2 , pp. 127-167
    • Wesnes, K.A.1    Parrott, A.2
  • 22
    • 85023123083 scopus 로고
    • Cognitive enhancement with physostigmine in young volunteers
    • Annual Meeting of the British Association for Psychopharmacology, Cambridge, July 1994
    • Wesnes, K.A., Simpson, P.M., Thompson, S, Wallnöfer, A, Dingemanse, J, McClelland, G, Malek, N, Cognitive enhancement with physostigmine in young volunteers., Annual Meeting of the British Association for Psychopharmacology, Cambridge, July 1994, 1994.
    • (1994)
    • Wesnes, K.A.1    Simpson, P.M.2    Thompson, S.3    Wallnöfer, A.4    Dingemanse, J.5    McClelland, G.6    Malek, N.7
  • 23
    • 0032900133 scopus 로고    scopus 로고
    • Relationships among age, CS–US interval and neuropsychological test performance
    • Woodruff-Pak, D.S., Jaegar, M.E., Golman, C, Wesnes, K.A., Relationships among age, CS–US interval and neuropsychological test performance. Neuropsychology 13 (1999), 90–102.
    • (1999) Neuropsychology , vol.13 , pp. 90-102
    • Woodruff-Pak, D.S.1    Jaegar, M.E.2    Golman, C.3    Wesnes, K.A.4
  • 24
    • 84959180457 scopus 로고    scopus 로고
    • Oxygen administration and cognitive performance in the elderly: a case of selective enhancement
    • Moss, M.C., Scholey, A.B., Neave, N, Stubbs, P, Wesnes, K.A., Oxygen administration and cognitive performance in the elderly: a case of selective enhancement. J. Psychopharmacol., 12(Supplement A), 1998, A41.
    • (1998) J. Psychopharmacol. , vol.12 , pp. A41
    • Moss, M.C.1    Scholey, A.B.2    Neave, N.3    Stubbs, P.4    Wesnes, K.A.5
  • 26
    • 0026390289 scopus 로고
    • First clinical impressions with an ACTH analogue (HOE 427) in the treatment of Alzheimer's disease
    • Siegfried, K, First clinical impressions with an ACTH analogue (HOE 427) in the treatment of Alzheimer's disease. Ann. N. Y. Acad. Sci. 640 (1991), 260–283.
    • (1991) Ann. N. Y. Acad. Sci. , vol.640 , pp. 260-283
    • Siegfried, K.1
  • 30
    • 0033984631 scopus 로고    scopus 로고
    • Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers
    • Wesnes, K.A., Garratt, C, Wickens, M, Gudgeon, A, Oliver, S, Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers. Br. J. Clin. Pharmacol. 49 (2000), 110–117.
    • (2000) Br. J. Clin. Pharmacol. , vol.49 , pp. 110-117
    • Wesnes, K.A.1    Garratt, C.2    Wickens, M.3    Gudgeon, A.4    Oliver, S.5
  • 32
    • 0032973812 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled trial of intravenous flumazenil in Alzheimer's disease
    • Templeton, L, Barker, A, Wesnes, K, Wilkinson, D, A double-blind, placebo-controlled trial of intravenous flumazenil in Alzheimer's disease. Hum. Psychopharmacol. 14 (1999), 239–245.
    • (1999) Hum. Psychopharmacol. , vol.14 , pp. 239-245
    • Templeton, L.1    Barker, A.2    Wesnes, K.3    Wilkinson, D.4
  • 33
    • 0021170003 scopus 로고
    • The separate and combined effects of scopolamine and nicotine on human information processing
    • Wesnes, K, Revell, A, The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology 84 (1984), 5–11.
    • (1984) Psychopharmacology , vol.84 , pp. 5-11
    • Wesnes, K.1    Revell, A.2
  • 34
    • 0025381490 scopus 로고
    • Group report 3: early clinical testing of cognition enhancers: prediction of efficacy
    • Hall, S.T., Puech, A, Schaffler, K, Wesnes, K, Gamzu, E.R., Group report 3: early clinical testing of cognition enhancers: prediction of efficacy. Pharmacopsychiatry 23 (1990), 57–60.
    • (1990) Pharmacopsychiatry , vol.23 , pp. 57-60
    • Hall, S.T.1    Puech, A.2    Schaffler, K.3    Wesnes, K.4    Gamzu, E.R.5
  • 36
    • 85023073269 scopus 로고
    • The ‘scopolamine model of some core cognitive deficits seen in Alzheimer's disease’: same model, slightly different name
    • Wesnes, K.A., The ‘scopolamine model of some core cognitive deficits seen in Alzheimer's disease’: same model, slightly different name. J. Psychopharmacol., 9, 1995, A7 Suppl.
    • (1995) J. Psychopharmacol. , vol.9 , pp. A7
    • Wesnes, K.A.1
  • 38
    • 0031955434 scopus 로고    scopus 로고
    • Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance
    • Ebert, U, Oertel, R, Wesnes, K.A., Kirch, W, Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance. Hum. Psychopharmacol. 13 (1998), 199–210.
    • (1998) Hum. Psychopharmacol. , vol.13 , pp. 199-210
    • Ebert, U.1    Oertel, R.2    Wesnes, K.A.3    Kirch, W.4
  • 39
    • 0027748339 scopus 로고
    • Pharmacodynamic and early clinical studies with velnacrine
    • Siegfried, K.R., Pharmacodynamic and early clinical studies with velnacrine. Acta Neurol. Scand. 149 (1993), 26–28 Suppl.
    • (1993) Acta Neurol. Scand. , vol.149 , pp. 26-28
    • Siegfried, K.R.1
  • 40
    • 0025673863 scopus 로고
    • The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers
    • Wesnes, K.A., Anand, R, Simpson, P.M., Christmas, L, The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers. J. Psychopharmacol. 4 (1990), 219–232.
    • (1990) J. Psychopharmacol. , vol.4 , pp. 219-232
    • Wesnes, K.A.1    Anand, R.2    Simpson, P.M.3    Christmas, L.4
  • 41
    • 0023228040 scopus 로고
    • The use of a scopolamine model to study the nootropic effects of tenilsetam (CAS 997) in man
    • Wesnes, K, Simpson, P.M., Kidd, A.G., The use of a scopolamine model to study the nootropic effects of tenilsetam (CAS 997) in man. Med. Sci. Res. 15 (1987), 1063–1064.
    • (1987) Med. Sci. Res. , vol.15 , pp. 1063-1064
    • Wesnes, K.1    Simpson, P.M.2    Kidd, A.G.3
  • 42
    • 0025120689 scopus 로고
    • Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of ageing and dementia
    • Wesnes, K, Anand, R, Lorscheid, T, Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of ageing and dementia. Acta Psychiatr. Scand. 82 (1990), 71–72.
    • (1990) Acta Psychiatr. Scand. , vol.82 , pp. 71-72
    • Wesnes, K.1    Anand, R.2    Lorscheid, T.3
  • 43
    • 27544466859 scopus 로고    scopus 로고
    • FK960 antagonises the memory impairments produced by scopolamine in healthy volunteers
    • Wesnes, K.A., Ramezani, E, Oliver, S, FK960 antagonises the memory impairments produced by scopolamine in healthy volunteers. J. Psychopharmacol., 11, 1997, A57 Suppl.
    • (1997) J. Psychopharmacol. , vol.11 , pp. A57
    • Wesnes, K.A.1    Ramezani, E.2    Oliver, S.3
  • 44
    • 0000121224 scopus 로고
    • The effects of D-cycloserine, a glycine agonist, in a human model of the cognitive deficits associated with ageing and dementia
    • Wesnes, K.A., Jones, R.W., Kirby, J, The effects of D-cycloserine, a glycine agonist, in a human model of the cognitive deficits associated with ageing and dementia. Br. J. Clin. Pharmacol. 31 (1991), 577P–578P.
    • (1991) Br. J. Clin. Pharmacol. , vol.31 , pp. 577P-578P
    • Wesnes, K.A.1    Jones, R.W.2    Kirby, J.3
  • 45
    • 0344503022 scopus 로고
    • D-Cycloserine antagonises scopolamine induced memory impairment and improves attention in the elderly
    • Wesnes, K, Jones, R, Kirby, J, Curtis, L, D-Cycloserine antagonises scopolamine induced memory impairment and improves attention in the elderly. Biol. Psychiatry 29 (1991), 700S–701S.
    • (1991) Biol. Psychiatry , vol.29 , pp. 700S-701S
    • Wesnes, K.1    Jones, R.2    Kirby, J.3    Curtis, L.4
  • 47
    • 4243574696 scopus 로고    scopus 로고
    • Development and validation of a system for evaluating cognitive functioning over the telephone for use in late phase drug development
    • Wesnes, K.A., Ward, T, Ayre, G, Pincock, C, Development and validation of a system for evaluating cognitive functioning over the telephone for use in late phase drug development. Eur. Neuropsychopharmacol., 9(Suppl. 5), 1999, S368.
    • (1999) Eur. Neuropsychopharmacol. , vol.9 , pp. S368
    • Wesnes, K.A.1    Ward, T.2    Ayre, G.3    Pincock, C.4
  • 48
    • 85023137853 scopus 로고    scopus 로고
    • Validation of a telephone cognitive assessment battery in chronic fatigue syndrome (CFS)
    • McCue, P, Scholey, A.B., Wesnes, K.A., Herman, C, Validation of a telephone cognitive assessment battery in chronic fatigue syndrome (CFS). J. Psychopharmacol., 14, 2000, A43.
    • (2000) J. Psychopharmacol. , vol.14 , pp. A43
    • McCue, P.1    Scholey, A.B.2    Wesnes, K.A.3    Herman, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.